NAACCR Item #3890: Microsatellite Instability (MSI)
|Item #||Length||Source of Standard||Year Implemented||Version Implemented||Year Retired||Version Retired|
NAACCR XML: Tumor.microsatelliteInstability
Microsatellite Instability (MSI) is a form of genetic instability manifested by changes in the length of repeated single- to six-nucleotide sequences (known as DNA microsatellite sequences). High MSI, found in about 15% of colorectal carcinomas, is an adverse prognostic factor for colorectal carcinomas and predicts poor response to 5-FU chemotherapy (although the addition of oxaliplatin in FOLFOX regimens negates the adverse effects [page 266 AJCC manual]). High MSI is a hallmark of hereditary nonpolyposis colorectal carcinoma, also known as Lynch syndrome.
Microsatellite Instability (MSI) is a Registry Data Collection Variable in AJCC. It was previously collected as Colon and Rectum, CS SSF# 7.
|0||Microsatellite instability (MSI) stable; microsatellite stable (MSS); negative, NOS
Mismatch repair (MMR) intact, no loss of nuclear expression of MMR proteins
MMR proficient (pMMR or MMR-P)
|1||MSI unstable low (MSI-L)|
|2||MSI unstable high (MSI-H)
MMR deficient (dMMR or MMR-D), loss of nuclear expression of one or more MMR proteins
|8||Not applicable: Information not collected for this case
(If this information is required by your standard setter, use of code 8 may result in an edit error.)
|9||Not documented in medical record
Microsatellite instability not assessed or unknown if assessed
Each Site-Specific Data Item (SSDI) applies only to selected primary sites, histologies, and years of diagnosis. Depending on applicability and standard-setter requirements, SSDIs may be left blank.